Suzhou, Jiangsu, China In 2010 was created Crystal Pharmatech, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Suzhou.
We can highlight the next thriving fund investment areas, such as Outsourcing, Pharmaceutical. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the various public portfolio startups of the fund, we may underline Laviana Pharma Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Crystal Pharmatech, startups are often financed by Lotus Lake Ventures, Agricultural Fund of China. The meaningful sponsors for the fund in investment in the same round are LYFE Capital, HY Capital, ABC Capital.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.
| Fund Name | Location |
| 14th Street Global Ventures | - |
| Bitfinex | Taipei, Taiwan |
| CGF Capital Management | Chaoyang, China, Liaoning |
| EE Capital | Central, Central Region, Singapore |
| Front Row Ventures | Canada, Montréal, Quebec |
| GC | - |
| Insurance Australia Group (IAG) | Australia, New South Wales, Sydney |
| Las Olas Venture Capital (LOVC) | Florida, Fort Lauderdale, United States |
| Matignon Investissement & Gestion | France, Ile-de-France, Paris |
| Maya Partner Ltd. | - |
| Mitsubishi UFJ Financial Group | Chiyoda, Japan |
| Princeton Alumni Angels | - |
| RWI Group | California, Palo Alto, United States |
| Serendipity Partners | Norway, Oslo |
| Shanghai Fanzhong | China, Jiading District |
| Shenzhen Yijia Jiankang | China, Futian, Guangdong |
| Tabcorp Holdings Limited | Australia, Melbourne, Victoria |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Laviana Pharma | $15M | 02 Jan 2018 | Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Laviana Pharma | $15M | 02 Jan 2018 | Beijing |
